Innovation
9 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 232 times.
| Year | Filings |
|---|---|
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 1 |
Social engagement
Social engagement: 849 social following, 3 posts in the last 12 months — below the industry typical range.
Investor mix
4 investors on record; lead investors include Cystic Fibrosis Foundation, Orbimed.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 75% |
| Other / undisclosed | 1 | 25% |
Recent activity
4 Mar 2026
Milestone
regulatory